01385nam a22004097a 4500939001300000005001700013008004100030022002300071040002000094041000800114100001200122245019800134650002200332650002000354650002200374650001200396650001400408650001500422650003200437650003100469650002700500650002600527650001300553650001100566650001700577650001400594650002000608651002300628653001500651655001500666700001100681773006700692856016400759926001000923998000700933952003500940  a2020032520210615153910.0200325b2019    sp ||||| |||| 00| 0 spa d  a0955-3959 (online)  aSIISbspadsiis  aeng  aDay, E.  aPriorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs  aDrogodependencias  aDrogas ilegales  aVía intravenosa  aConsumo  aHepatitis  aOpiáceos  aIntercambio de jeringuillas  aProgramas de mantenimiento  aReducción de daños  aReducción de riesgo  aBarreras  aAcceso  aPrevención  aReuniones  aRecomendaciones  aAustralia91203459  aAdicciones  aDocumental  aet al.  gvol. 66, 2019, p. 87-93.tInternational Journal of Drug Policy  u\\Srvdatos\siis\docus\Revistas electrónicas\International Journal of Drug Policy R.1114\2019\Priorities and recommended actions for how researchers.pdfzPath  aAmaia  aAR  aSIScSISoArchivo (R.1114)yAR